Synthesis and evaluation of histamine H3 receptor ligand based on lactam scaffold as agents for treating neuropathic pain

Bioorg Med Chem Lett. 2019 Jun 15;29(12):1492-1496. doi: 10.1016/j.bmcl.2019.04.015. Epub 2019 Apr 8.

Abstract

The synthesis and H3 receptor ligand of a new series of lactam derivatives are reported. The new compounds were evaluated in vitro in H3 and H1 receptor-binding assays. The structure-activity relationship led us to the promising derivative 2-methyl-7-(3-morpholinopropoxy)-3,4-dihydroisoquinolin-1(2H)-one (11). The compound with highest affinity and greatest selectivity were further profiled, In addition, compound 11 exerted dose-dependent anti-nociceptive effects in the formalin test. These characteristics suggested that the potent and selective compound 11 could be a potent candidate for pain treatment.

Keywords: Anti-nociceptive; H(3) receptors; Synthesis.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Humans
  • Lactams / metabolism*
  • Ligands
  • Molecular Structure
  • Neuralgia / drug therapy*
  • Receptors, Histamine H3 / metabolism*

Substances

  • Lactams
  • Ligands
  • Receptors, Histamine H3